Clinical Trial Update: Phase II Study With Immunotherapy With Dendritic Cells and Tumor Infiltrating Lymphocytes in Solid Tumors [Phase 2]

View source ↗

Summary

Phase II trial evaluating dendritic cell-based immunotherapy in combination with tumor-infiltrating lymphocytes for solid tumors including renal cell carcinoma,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Melanoma
• Renal Cell Carcinoma

Drugs mentioned

• Dendritic cell vaccine
• Tumor Infiltrating Lymphocyte Therapy

Snippet

Sponsor: Clinica Universidad de Navarra, Universidad de Navarra | Conditions: Renal Cell Carcinoma, Melanoma | Phase 2 | Status: UNKNOWN